Lixte Biotechnology Holdings, Inc. schedules its 2024 Annual Meeting of Stockholders for December 19, 2024, to vote on the election of five director nominees, ratification of Weinberg & Company, P.A. as the independent registered public accounting firm, and approval of executive officer compensation. The meeting will be virtual, accessible via a live webcast.